0001614107-14-000001.txt : 20140723 0001614107-14-000001.hdr.sgml : 20140723 20140723171429 ACCESSION NUMBER: 0001614107-14-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20140723 DATE AS OF CHANGE: 20140723 EFFECTIVENESS DATE: 20140723 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Faraday Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001614107 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-221669 FILM NUMBER: 14989404 BUSINESS ADDRESS: STREET 1: 1616 EASTLAKE AVENUE E. STREET 2: SUITE 560 CITY: SEATTLE STATE: WA ZIP: 98102 BUSINESS PHONE: 2064528700 MAIL ADDRESS: STREET 1: 1616 EASTLAKE AVENUE E. STREET 2: SUITE 560 CITY: SEATTLE STATE: WA ZIP: 98102 D 1 primary_doc.xml X0707 D LIVE 0001614107 Faraday Pharmaceuticals, Inc. 1616 EASTLAKE AVENUE E. SUITE 560 SEATTLE WA WASHINGTON 98102 2064528700 DELAWARE Scion Pharmaceuticals, Inc. None Corporation true 2013 Mark Roth 1616 Eastlake Avenue E. Suite 560 Seattle WA WASHINGTON 98102 Executive Officer Director Promoter Steven Gillis 1616 Eastlake Avenue E. Suite 560 Seattle WA WASHINGTON 98102 Executive Officer Director Promoter Robert Nelsen 1616 Eastlake Avenue E. Suite 560 Seattle WA WASHINGTON 98102 Director Other Decline to Disclose 06b false 2014-07-09 false true false 0 6507274 3657274 2850000 false 4 0 0 0 false Faraday Pharmaceuticals, Inc. /s/ Steven Gillis Steven Gillis Executive Chairman 2014-07-23